In the first scenario, in contexts including pregnancy and obesity, an increased demand of vitamin B6 from specific PLP-dependent enzymes, as well as the trigger of inflammation pathways, can reduce its availability. The gene discussed is PDXP; the disease is obesity due to melanocortin 4 receptor deficiency.